US 9394364
Human monoclonal antibodies specific for glypican-3 and use thereof
granted A61KA61K2039/505A61K39/39558
Quick answer
US patent 9394364 (Human monoclonal antibodies specific for glypican-3 and use thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K2039/505, A61K39/39558, A61K47/6813, A61K47/6829